# Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy

> **NCT00027963** · PHASE3 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 100 (actual)

## Conditions studied

- Neurotoxicity
- Pain

## Interventions

- **DRUG:** gabapentin
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00027963
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-07-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00027963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00027963, "Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00027963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*